

          1. Patients with COVID 19 in critical condition or ARDS (Appendix A) or NIAID 7-point
             ordinal score 2 (Hospitalized, on invasive mechanical ventilation or extracorporeal
             membrane oxygenation (ECMO)).

          2. Patients with bacterial / fungal infections.

          3. Patients who are pregnant, breastfeeding, or have a positive pregnancy test result
             before enrollment.

          4. Severe liver damage (Child-Pugh score >= C, AST> 5 times the upper limit).

          5. Patients with known severe renal impairment (creatinine clearance <= 30 mL / min) or
             patients receiving continuous renal replacement therapy, hemodialysis, or peritoneal
             dialysis.

          6. Will be transferred to a non-study site hospital within 72 hours.

          7. The investigator believes that participating in the trial is not in the best interests
             of the patient, or the investigator considers unsuitable for enrollment (such as
             unpredictable risks or subject compliance issues).
      